Sterling Capital Management »

Artiva Biotherapeutics shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Artiva Biotherapeutics shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $478 31 15.45

More positions owned by Sterling Capital Management

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Vanguard S&p 500 Etf Etf (VOO)
Hershey Company (HSY)
Automatic Data Processing (ADP)
Home Depot (HD)
Anthem (ELV)
Ameriprise Financial (AMP)
Analog Devices (ADI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Charles Schwab Corporation (SCHW)
Nasdaq Omx (NDAQ)
Abbvie (ABBV)
Pepsi (PEP)

View all positions for Sterling Capital Management

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Capital World Investors
BlackRock
Franklin Resources
Geode Capital Management
Samsara BioCapital
Woodline Partners
Northern Trust
Citadel Advisors
Alyeska Investment Group
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Artiva Biotherapeutics